• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Introduction to 3-(2-phenyl-1,3-thiazol-4-yl)aniline and Its Applications in Modern Chemical Biology

3-(2-phenyl-1,3-thiazol-4-yl)aniline, a compound with the CAS number 134812-32-1, represents a significant advancement in the field of chemical biology and pharmaceutical research. This heterocyclic aromatic amine has garnered considerable attention due to its unique structural properties and potential therapeutic applications. The compound's molecular framework, featuring a thiazole ring fused with a phenyl group and an aniline moiety, provides a versatile platform for further chemical modifications and biological evaluations.

The synthesis of 3-(2-phenyl-1,3-thiazol-4-yl)aniline involves a series of well-established organic reactions, including condensation and cyclization processes. The presence of the thiazole ring is particularly noteworthy, as thiazole derivatives are widely recognized for their biological activity. This class of compounds has been extensively studied for their potential roles in antimicrobial, anti-inflammatory, and anticancer therapies. The incorporation of the phenyl group enhances the compound's lipophilicity, which can be advantageous for membrane permeability and bioavailability.

In recent years, there has been a surge in research focused on developing novel scaffolds that combine the functionalities of multiple heterocyclic systems. 3-(2-phenyl-1,3-thiazol-4-yl)aniline exemplifies this trend, as it merges the properties of thiazole and aniline moieties. Such hybrid structures often exhibit enhanced pharmacological profiles compared to their individual components. For instance, studies have shown that thiazole-aniline derivatives can interact with various biological targets, including enzymes and receptors, leading to potent therapeutic effects.

The aniline moiety in 3-(2-phenyl-1,3-thiazol-4-yl)aniline is particularly interesting from a chemical biology perspective. Anilines are known for their ability to participate in hydrogen bonding and π-stacking interactions, which can influence the compound's binding affinity to biological targets. Additionally, the phenyl group introduces additional aromaticity, further enhancing these interactions. These structural features make 3-(2-phenyl-1,3-thiazol-4-yl)aniline a promising candidate for drug discovery efforts aimed at developing new treatments for complex diseases.

Recent advancements in computational chemistry have enabled more efficient screening of potential drug candidates like 3-(2-phenyl-1,3-thiazol-4-yl)aniline. Molecular docking studies have been instrumental in predicting the binding modes of this compound with various biological targets. For example, research has indicated that it may interact with enzymes involved in signal transduction pathways relevant to cancer progression. These findings underscore the importance of computational tools in accelerating the drug discovery process and identifying lead compounds with high therapeutic potential.

The pharmaceutical industry has shown particular interest in thiazole derivatives due to their broad spectrum of biological activities. 3-(2-phenyl-1,3-thiazol-4-yl)aniline is no exception and has been explored as a precursor for several novel drug candidates. Its structural versatility allows for modifications that can fine-tune its pharmacological properties. For instance, introducing substituents at specific positions on the thiazole or aniline rings can alter its solubility, metabolic stability, and target specificity.

In conclusion, 3-(2-phenyl-1,3-thiazol-4-yl)aniline (CAS number 134812-32-1) represents a compelling example of how combining different heterocyclic systems can yield compounds with enhanced biological activity. Its unique structural features make it a valuable scaffold for further exploration in chemical biology and pharmaceutical research. As our understanding of molecular interactions continues to evolve, compounds like 3-(2-phenyl-1,3-thiazol-4-y lanine) are poised to play a crucial role in the development of next-generation therapeutics.

• 2227-61-4(4-Phenyl-2-(p-tolyl)thiazole)
• 1826-14-8(Thiazole, 2,4-diphenyl-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)